Daily Crunch: Reviewing the biggest and smallest new iPhones

We review the iPhone 12 Pro Max and the iPhone 12 mini, Zoom settles with the FTC and Pfizer announces promising results for its COVID-19 vaccine trial. This is your Daily Crunch for November 9, 2020.

The big story: Reviewing the biggest and smallest new iPhones

TechCrunch Editor in Chief Matthew Panzarino tackled both extremes of the new iPhone 12 lineup today, publishing reviews of the Pro Max and the mini.

It sounds like he’s impressed with both of them. The iPhone 12 Pro Max, he writes, has “a really, really great camera” — the question is whether you’re willing to make the ergonomic trade-off, since you’ll probably need to use two hands with the larger phone. At the same time, he suggests that the iPhone 12 mini might be “the most attractive phone in the lineup.”

As if that wasn’t enough, Matthew also checked out the MagSafe Duo charger, a dual magnetic charger that he found underwhelming.

The tech giants

Zoom settles with FTC after making ‘deceptive’ security claims — The FTC previously accused Zoom of engaging in “a series of deceptive and unfair practices,” in part by claiming its encryption was stronger than it actually was.

Adobe acquires marketing workflow startup Workfront for $1.5B — This deal gives Adobe more online marketing tooling to fit into its Experience Cloud.

Beyond Meat shares rise on news that it collaborated with McDonald’s on the McPlant options — While McDonald’s initial announcement made it sound like the McPlant was developed entirely in-house, the new vegetarian option is actually a collaboration with Beyond Meat.

Startups, funding and venture capital

Autonomous delivery startup Nuro hits $5 billion valuation on fresh funding of $500 million — Nuro was founded in June 2016 by former Google engineers Dave Ferguson and Jiajun Zhu.

MSCHF’s Push Party raises an unconventional seed round at a $200 million valuation — MSCHF is poking a little fun at the venture industry and perhaps publications like TechCrunch, too.

Bumble’s new feature prevents bad actors from using ‘unmatch’ to hide from their victims — This will make it harder for harassers to avoid having their conversation reported to Bumble’s safety team.

Advice and analysis from Extra Crunch

Five UX design research mistakes you can stop making today — Jason Buhle writes that while working with startups and tech companies, he’s seen that even people who understand the importance of user research don’t necessarily know how to conduct it in optimal ways.

What happens to high-flying startups if the pandemic trade flips? — An effective vaccine trial is shaking up public companies, unicorns and startups.

What we’ve learned about working from home seven months into the pandemic — We interview Karen Mangia, vice president of customer and market insights at Salesforce and author of “Working from Home, Making the New Normal Work for You.”

(Reminder: Extra Crunch is our membership program, which aims to democratize information about startups. You can sign up here.)

Everything else

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial — This reflects only early results from the trial, rather than the final verified result, but it’s still extremely promising.

NASA partners with SpaceX, Rocket Lab, Blue Origin and others for test flights and research — While no money will change hands, NASA will dedicate millions in personnel and other support to these test launches and developing technologies.

Original Content podcast: ‘The Queen’s Gambit’ is the historical chess drama we need right now — Somehow, the show makes competitive chess seem thrilling.

The Daily Crunch is TechCrunch’s roundup of our biggest and most important stories. If you’d like to get this delivered to your inbox every day at around 3pm Pacific, you can subscribe here.